TīmeklisEfalizumab (nom de spécialité Raptiva, Genentech, Merck Serono) est un médicament conçu pour traiter les maladies auto-immunes et initialement commercialisé pour traiter le psoriasis. Comme le suggère le suffixe -zumab, c'est un anticorps monoclonal recombinant humanisé (chimère homme-souris). Tīmeklis2013. gada 8. maijs · Tragedy of Efalizumab (Raptiva) Raptiva was approved in 2003 for the treatment of psoriasis in adults . Patients were reported with serious infections of nervous system . Later on drug was found to be associated with life threatening diseases of nervous system e. g. Progressive Multifocal leukoencephalopathy (PML), …
Efalizumab - Wikipedia
TīmeklisEfalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat … TīmeklisCD11a Monoclonal Antibody (M17/4), FITC, Invitrogen™-Rat Monoclonal Antibody Achetez CD11a Monoclonal Antibody (M17/4), FITC, Invitrogen™ sur Fishersci.fr farnborough home show
Side Effects of Raptiva (efalizumab): Interactions & Warnings - MedicineNet
TīmeklisEfalizumab (Raptiva, Serono) is a humanised monoclonal antibody (IgG1) produced by biotechnology. This antibody has a novel place among biotherapies for psoriasis. It is bound to the CD11a subunit of a surface molecule of the T lymphocyte LFA-1 (Leucocyte Function-associated Antigen-1). This molecule is essential for binding of … Tīmeklis2005. gada 21. jūn. · Treatment with efalizumab (anti-CD11a) within the last 12 months before enrollment; Pregnancy or lactation. As the risk of Efalizumab in pregnancy is unknown, pregnant women will be excluded from the study; History of or ongoing uncontrolled bacterial, viral, fungal, or atypical mycobacterial infection Tīmeklis2024. gada 8. nov. · Raptiva is a man-made form of a protein similar to human antibodies. Efalizumab is made to target and destroy only certain cells in the body. … free standing boxing bag children